UC1MT

FIRST-IN-CLASS ANTI-METALLOTHIONEIN ANTIBODY FOR AUTOIMMUNE AND INFLAMMATORY DISEASES

The UC1MT discovery program is focused on the development of a therapeutic antibody targeting extracellular metallothinein (MT), a stress response protein synthesized during infection, inflammation, and autoimmune diseases.

UC1MT is a high affinity monoclonal antibody that recognizes both mouse and human MT1 and MT2

Biohaven UC1MT monoclonal antibody human MT1 and MT2